PDL1 expression is associated with longer postoperative, survival in adrenocortical carcinoma

Adrenocortical carcinomas (ACCs) are heterogeneous cancers associated with a very poor prognosis. The improvement of prognostic tools and systemic therapy are urgently needed. Targeting the immune system using checkpoint inhibitors such as PD1/PDL1 inhibitors is an attractive novel therapeutic strat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncoimmunology
Hauptverfasser: Billon, Emilien, Finetti, Pascal, Bertucci, Alexandre, Niccoli, Patricia, Birnbaum, Daniel, Mamessier, Emilie, Bertucci, François
Format: Artigo
Sprache:Inglês
Veröffentlicht: Taylor & Francis 2019
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6791455/
https://ncbi.nlm.nih.gov/pubmed/31646101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2019.1655362
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge